Pradaxa is a blood thinner medicine that helps treat atrial fibrillation. Atrial fibrillation causes the heart to stop beating which can result in the formation of blood clots and increase the risk of suffering a stroke. Pradaxa is supposed to help reduce that risk of stroke and blood clots.
Pradaxa (dabigatran)
Manufacturer: Boehringer Ingelheim
Recently, Pradaxa has received a large number of claims due to patients suffering side effects including:
Pradaxa does warn users of possible internal bleeding but lawsuits are being filed against Pradaxa. It is believed that the drug creates a greater risk for internal bleeding than warned by the company. The bleeding has a high risk of being irreversible with no known antidote available to reverse the drug’s anti-clotting effects. A Pradaxa FDA warning was issued after 542 deaths were reported from associated use of Pradaxa.
With experience in multi-million dollar recoveries, Goldblatt + Singer is ready to represent you and help you receive the compensation you need for Pradaxa’s neglect to warn their users. Don’t waste any more time, spend another dollar on medical bills or lose wages due to Pradaxa related injuries. Contact us or call us toll-free.
fields required *